- Feb 2019
The conceptual framework we seek must orient us toward the real possibilities and problems associated with using modern technology to give direct aid to an individual in comprehending complex situations, isolating the significant factors, and solving problems.
This problem of orientation is more true today than ever and I'm just not convinced that Silicon Valley (however well-intentioned) represents the right group to devise a framework to truly serve EVERYONE.
Anyone interested in joining a grassroots effort to help influence those at the top? Let me know - wkendal-at-gmail
- Jan 2019
Adipose tissue is no longer considered to be an inert tissue that stores fat. This tissue is capable of expanding to accommodate increased lipids through hypertrophy of existing adipocytes and by initiating differentiation of pre-adipocytes. Adipose tissue metabolism exerts an impact on whole-body metabolism. As an endocrine organ, adipose tissue is responsible for the synthesis and secretion of several hormones. These are active in a range of processes, such as control of nutritional intake (leptin, angiotensin), control of sensitivity to insulin and inflammatory process mediators (tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), resistin, visfatin, adiponectin, among others) and pathways (plasminogen activator inhibitor 1 (PAI-1) and acylation stimulating protein (ASP) for example). This paper reviews some of the biochemical and metabolic aspects of adipose tissue and its relationship to inflammatory disease and insulin resistance.
- Plasminogen Activator Inhibitor 1
- Acylation Stimulating Protein
- Insulin Resistance
- Endocrine Organ
- Adipose Tissue
- Tumor Necrosis Factor α